| Identification | Back Directory | [Name]
Research Grade Opinercept (DHB94411) | [CAS]
2055118-96-0 | [Synonyms]
Research Grade Opinercept
Research Grade Opinercept (DHB94411) |
| Hazard Information | Back Directory | [Uses]
Opinercept is a recombinant fusion protein comprising an TNFRSF1B fused to a human IgG1 Fc[1]. Opinercept is a tumor necrosis factor-alpha (TNF-alpha) inhibitor. Opinercept can be used for the research of rheumatoid arthritis (RA)[1]. | [References]
[1] Liang TH, et al. Efficacy and Safety of Opinercept Tumor Necrosis Factor Inhibitor Therapy for Drug-Refractory Rheumatoid Arthritis: A Randomized Clinical Trial. Arch Rheumatol. 2020 Jan 8;35(2):170-179. DOI:10.46497/ArchRheumatol.2020.7464 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
|